Navigation Links
Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
Date:8/2/2009

XA manufactured using the proposed commercial manufacturing process. The Company currently expects that it will seek to address this issue by reverting to and revalidating the manufacturing process used to produce KRYSTEXXA for the Phase 3 clinical trials.

The complete response letter also stated that the FDA has determined that a REMS is necessary for KRYSTEXXA consisting of:

  • A Medication Guide to ensure the safe and effective use of KRYSTEXXA by patients,
  • A Communication Plan directed to healthcare providers likely to prescribe KRYSTEXXA to support the dissemination of information about the risks of severe infusion reactions and possible anaphylaxis, the risk of severe adverse reactions in administering KRYSTEXXA to patients with glucose-6-phopshate dehydrogenase (G6PD) deficiency and major cardiovascular events, and
  • An Assessment Plan to monitor and assess the effectiveness of the Medication Guide and Communication Plan in communicating to patients and physicians an understanding of the risks of KRYSTEXXA treatment.

The complete response letter included additional CMC comments focused on tightening manufacturing parameters and narrowing analytical specifications associated with commercial production. The Company was also informed that its resubmission to the FDA in response to the complete response letter must include an update of safety data from all on-going studies. Additionally, the Company's drug substance manufacturer BTG-Israel has already provided a work plan to remediate observations arising from the FDA pre-approval inspection of BTG-Israel's manufacturing facility and a satisfactory inspection report is required prior to the approval of KRYSTEXXA.

"While our timeline for resubmission to the FDA is subject to a number of uncertainties, we currently believe that we can target completion of our resubmission for early 201
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 The American College of Traditional ... for the Open House/Free Application Day on Wednesday, July 22. ... 4 p.m. and will be held at ACTCM Pioneer Square, ... After checking in, attendees will be greeted with an introduction ... of the campus at 11:45 a.m. Lunch will be served ...
(Date:5/26/2015)... May 26, 2015 Abington is ... Wellness, a physician practice with seven medical professionals, ... the eighth primary-care site in the United States ... medical home by the National Committee for Quality ... primary, preventative and sick care – including routine ...
(Date:5/26/2015)... 26, 2015 It was an evening ... in Colorado. On Wednesday, May 13, The Denver Foundation ... new era of community-based giving with its Annual Celebration, ... in the Making,” the event celebrated the donors, leaders, ... to mobilize resources for good. , “If your organization, ...
(Date:5/26/2015)... Allprovide, the all-natural raw pet food company, today ... now available in three Georgia stores: Pooch-n-Paws in Suwannee; ... Dog Company in Kennesaw. , Allprovide is based out ... climate controlled facility. The fresh ingredients come from select ... food is triple-tested for quality. Unlike most pet foods, ...
(Date:5/26/2015)... Downers Grove, IL (PRWEB) May 26, 2015 ... Worker who is an expert in Neuro-Linguistic Programming, or ... a Master Practitioner in Rapid Resolution Therapy® or RRT®. ... the field of NLP and applied it to specific ... NLP to psychological treatment for over 20 years. ...
Breaking Medicine News(10 mins):Health News:ACTCM to Host Summer Open House 2Health News:Family Medicine, Geriatrics and Wellness Joins Abington Health Physicians 2Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Allprovide, the All-Natural Pet Food, Available At Georgia Retailers 2
... initiatives to encourage healthy eating habits, teens in middle ... 1999, a new study reveals.// And the situation only ... vegetable intake is important for the prevention of future ... Larson, M.P.H. “So it’s important to know whether intakes ...
... recent study by a Saint Louis University researcher confirms findings ... of a gene that causes them to metabolize food// differently, ... ,Edward Weiss, Ph.D., assistant professor of nutrition and dietetics ... looked at a relatively common version of a gene called ...
... by biochemists at the University of California, San Diego ... which inflammation can promote cancer. The findings// may provide ... ,The study shows that what scientists thought were two ... cells’ response to dangers such as invading organisms—are actually ...
... has shown conclusively that a neuropeptide, melanin concentrating hormone ... role in// increasing appetite in people, plays a role ... secretion of insulin. This finding has the potential to ... stimulate the production of insulin-producing beta cells in the ...
... simple scoring system for use by physicians predicts early risk ... known as TIA and also called// a "mini-stroke," according to ... every year in the United States and about 70,000 in ... by temporary reduction in blood and oxygen supply to part ...
... range from the very serious Fetal Alcohol Syndrome to ... Disorders. The timing of alcohol consumption, its frequency, the ... elements of identifying risk. A new survey has found ... consumed alcohol during the three months before pregnancy; nearly ...
Cached Medicine News:Health News:Today’s Teens Slacking on Fruit, Veggie Intak 2Health News:Molecular Link Between Inflammation and Cancer Discovered 2Health News:Molecular Link Between Inflammation and Cancer Discovered 3Health News:Role of Appetite Hormone MCH in Insulin Production Revealed 2Health News:New Tool Improves Prediction of Stroke Risk 2Health News:Risk Factors of Drinking Before, and During, Pregnancy 2
(Date:5/26/2015)... Sanomedics, Inc. (OTC: SIMH) an international medical technology company ... growing behavioral health sector with the strategic acquisition of ... as a Services (SaaS) provider, specialized in Electronic Health ... centers. "The strategic acquisition of Zen ... health sector where the number of treatment service and ...
(Date:5/26/2015)... , May 26, 2015  MGC Diagnostics Corporation (NasdaqCM: MGCD), ... to discuss its financial results for the second quarter of ... at 4:30 p.m. ET on Tuesday, June 2, 2015. The ... fiscal 2015 at the close of the markets on Tuesday, ... 317-6789 or (412) 317-6789 to access the conference call, or ...
(Date:5/26/2015)... 2015 Boehringer Ingelheim today announced that ... once-daily STIOLTO™ RESPIMAT ® (tiotropium bromide and ... a long-term, once-daily maintenance treatment of airflow obstruction ... including chronic bronchitis and/or emphysema. STIOLTO RESPIMAT is ... of COPD. COPD, which includes chronic ...
Breaking Medicine Technology:Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 2Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 3MGC Diagnostics Corporation to Report Second Quarter Fiscal 2015 Financial Results on Tuesday, June 2, 2015 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13
... 2012  Vitamin Shoppe, Inc. (NYSE: VSI ), ... products, today announced that it will be participating at ... Retail Conference taking place March 7 - 8, 2012 ... be Mike Archbold, President and COO and Brenda Galgano, ...
... Feb. 29, 2012 Talyst , a leader in ... annual 340B Coalition Winter Conference. The new tool allows health ... The 340B Savings Calculator lets health systems predict their ... "Talyst is dedicated to ensure you receive ...
Cached Medicine Technology:Vitamin Shoppe, Inc. Announces Participation at Investor Conference 2
... In 2000, Applied Biosystems introduced ... I S M 3100 Genetic Analyzer.,Now ... instrument is available in our new ... for low- to-medium-throughput laboratory needs, the ...
... Quality Analysis System) developed by Pablo Artal, ... first diagnostic tool for ophthalmology that provides ... system. Never before has an ophthalmologist had ... quality of vision. , ,OQAS works by ...
... kit uses proteins produced with recombinant technology, that ... which are capable of detecting the different types ... are proteins with amino acid sequences repeated in ... the acute phase of the infection, it reacts ...
Elisa test for qualitative detection of Total antibodies to Trypanosoma Cruzi in human serum or plasma....
Medicine Products: